WDR4 and nasopharyngeal carcinoma: Elevated expression of METTL1/WDR4 mediates m7G tRNA modification, activates the WNT/β-catenin pathway, and promotes EMT and chemoresistance to cisplatin and docetaxel in nasopharyngeal carcinoma (NPC) cells [169].